NF-KB-Lnhibited acute myeloid leukemia cells are rescued from apoptosis by heme oxygenase-1 induction

Cancer Research

Volumn 70, Issue 7, 2010, Pages 2973-2983

  Rushworth, Stuart A ^a   Bowles, Kristian M ^b   Raninga, Prahlad ^a   MacEwan, David J ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; SYNAPTOTAGMIN I; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 3-(4-METHYLPHENYLSULFONYL)-2-PROPENENITRILE; ANTINEOPLASTIC AGENT; NFE2L2 PROTEIN, HUMAN; NITRILE; REACTIVE OXYGEN METABOLITE; SULFONE; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR RELA;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ACUTE DISEASE; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; GENETICS; METABOLISM; MYELOID LEUKEMIA; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; TUMOR CELL CULTURE;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CHROMATIN IMMUNOPRECIPITATION; ENZYME INDUCTION; HEME OXYGENASE-1; HUMANS; LEUKEMIA, MYELOID; NF-E2-RELATED FACTOR 2; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; NITRILES; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; SULFONES; TRANSCRIPTION FACTOR RELA; TUMOR CELLS, CULTURED;

EID: 77950819906     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-3407     Document Type: Article

References (43)

1. The Leukemia and Lymphoma Society. Available from: http://www. leukemia-lymphoma.org/
2. Stapnes C, Doskeland AP, Hatfield K, et al. The proteasome inhibitors bortezomib and PR-171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells. Brit J Haematol 2007;136:814-828
3. Guzman ML, Neering SJ, Upchurch D, et al. Nuclear factor-KB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 2001;98:2301-2307
4. Mathas S, Johrens K, Joos S, et al. Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas. Blood 2005;106: 4287-4293
5. Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia 2000;14:399-402. (Pubitemid 30142862)
6. Pacifico F, Leonardi A. NF-κB in solid tumors. Biochem Pharmacol 2006;72:1142-1152
7. Rushworth SA, MacEwan DJ. HO-1 underlies resistance of AML cells to TNF-indueed apoptosis. Blood 2008;111:3793-3801
8. Tenhunen R, Harvey T, Amarver S, Scmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 1968;61:748-755
9. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase1: unleashing the protective properties of heme. Trends Immunol 2003;24:449-455
10. Rushworth SA, Chen XL, Mackman N, Ogborne RM, O'Connell MA. Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C J Immunol 2005;175:4408-4415
11. Camara NOS, Soares MP. Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free Radical Biol Med 2005;38:426-435
12. Loboda A, Jazwa A, Grochot-Przeczek A, et al. Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2008;10:1767-1812
13. Jozkowicz A, Was H, Dulak J. Heme oxygenase-1 in tumors: is it a false friend? Antioxid Redox Signal 2007;9:2099-2117
14. Mayerhofer M, Gleixner KV, Mayerhofer J, et al. Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib. Blood 2008;111:2200-2210
15. Berberat PO, Dambrauskas Z, Gulbinas A, et al. Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res 2005;11:3790-3798
16. Pietsch EC, Chan JY, Torti FM, Torti SV. Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones. J Biol Chem 2003;278:2361-2369
17. Ogbome RM, Rushworth SA, O'Connell MA. α-Lipoic acid-induced heme oxygenase-1 expression is mediated by nuclear factor erythroid 2-related factor 2 and p38 mitogen-activated protein kinase in human monocytic cells. Arterioscl Thrombosis Vase Biol 2005; 25:2100-2105
18. Ogbome RM, Rushworth SA, Charalambos CA, O'Connell MA. Haem oxygenase-1 : a target for dietary antioxidants. Biochem Soc Trans 2004;32:1003-1005
19. Liu XM, Peyton KJ, Ensenat D, et al. Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovasc Res 2007; 75:381-389 (Pubitemid 46961918)
20. Trekli MC, Riss G, Goralczyk R, Tyrrell RM. β-Carotene suppresses UVA-induced HO1 gene expression in cultured FEK4. Free Radical Biol Med 2003;34:456-464
21. Camhi SL, Alam J, Wiegand GW, Chin BY, Choi AMK. Transcriptional activation of the H0-1 gene by lipopolysaccharide is mediated by 5' distal enhancers: role of reactive oxygen intermediates and AP-1. Am J Resp Cell Mol Biol 1998;18:226-234
22. Alam J, Stewart D, Touchard C, Boinapally S, Choi AMK, Cook JL. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 1999;274:26071-26078 (Pubitemid 129520030)
23. Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, Abraham NG. Identification of binding-sites for transcription factors NF-κB and AP2 in the promoter region of the human heme oxygenase-1 gene. Proc Natl Acad Sci U S A 1994;91:5987-5991
24. Kurata SI, Matsumoto M, Tsuji Y, Nakajima H. Lipopolysaccharide activates transcription of the heme oxygenase gene in mouse M1 cells through oxidative activation of nuclear factor KB. Eur J Biochem 1996;239:566-571 (Pubitemid 26253072)
25. Lin CC, Chiang LL, Lin CH, et al. Transforming growth faetor-β1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-κB pathways in human lung epithelial cells. Eur J Pharmacol 2007;560: 101-109
26. Alam J, Cook JL. How many transcription factors does it take to turn on the heme oxygenase-1 gene?. Am J Respir Cell Mol Biol 2007;36: 166-174 (Pubitemid 46233469)
27. Rae C, Langa S, Tucker SJ, MacEwan DJ. Elevated NF-κB responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosis. Proc Natl Acad Sei U S A 2007;104:12790-12795
28. Cordle SR, Donald R, Read MA, Hawiger J. Lipopolysaccharide induces phosphorylation of Mad3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1 cells. J Biol Chem 1993; 268:11803-11810
29. Chi L, Ke Y, Luo C, Gozai D, Liu R. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neurosci 2007;144:991-1003. (Pubitemid 46013990)
30. Rushworth SA, MacEwan DJ, O'Connell MA. Lipopolysaccharideinduced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes. J Immunol 2008;181:6730-6737
31. Rushworth SA, O'Connell MA. Heme oxygenase-1 in inflammation. Biochem Soc Trans 2004;32:1093-1094
32. Fang J, Akaike T, Maeda H. Antiapoptotie role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment. Apoptosis 2004;9:27-35.
33. Dai Y, Rahmani M, Dent P, Grant S. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-κB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation. Mol Cell Biol 2005;25:5429-5444
34. Durante W. Heme oxygenase-1 in growth control and its clinical application to vascular disease. J Cell Physiol 2003;195: 373-382
35. Ferris CD, Jaffrey SR, Sawa A, et al. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1999;1:152-157
36. Brouard S, Otterbein LE, Anrather J, et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000;192:1015-1025
37. Minetti M, Mallozzi C, Di Stasi AMM, Pietraforte D. Bilirubin is an effective antioxidant of peroxynitrite-medicated protein oxidation in human blood plasma. Arch Biochem Biophys 1998;352: 165-174
38. De Smaele E, Zazzeroni F, Papa S, et al. Induction of GADD45β by NF-βB downregulates pro-apoptotic JNK signalling. Nature 2001; 414:308-313
39. Tang GL, Minemoto Y, Dibling B, et al. Inhibition of JNK activation through NF-βB target genes. Nature 2001;414:313-317
40. Wei L, Sandbulte MR, Thomas PG. NFKB negatively regulates interferon-induced gene expression and anti-influenza activity. J Biol Chem 2006;281:11678-11684
41. White DE, Burchill SA. BAY 11-7082 induces cell death through NF-βB-independent mechanisms in the Ewing's sarcoma family of tumours. Cancer Lett 2008;268:212-224
42. Faraonio R, Vergara P, Di Marzo D, et al. p53 suppresses the Nrf2dependent transcription of antioxidant response genes. J Biol Chem 2006;281:39776-39784
43. Hann IM, Stevens RF, Goldstone AH, et al. Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council. Blood 1997;89:2311-2318